← The Wire
CRBPNasdaq
Corbus Pharmaceuticals Holdings, Inc.
Pharmaceutical Preparations · DE · CIK 1595097
Corbus Pharmaceuticals develops new therapies for oncology and obesity
red 8-K · 90d🔥 High media attention
$152M
Market cap
$8.98
Last close
+2.8%
1D
+8.1%
5D
418K
Volume
Price · last 39 sessions-14.6%
May 4L $7.38 · H $12.15Jun 29
295
Total filings
May 26, 2026
Last filing
12/31
Fiscal year end
8-K/ACompany UpdateFeb 2, 20248-K/AExecutive ChangeApr 24, 20238-K/ASecurity-Holder RightsFeb 15, 20238-K/AExecutive ChangeSep 22, 20218-K/AExecutive ChangeDec 4, 20208-K/AExecutive ChangeApr 21, 2020
Insider Activity
In the 90 days to Mar 2, 2026: 5 sold $592K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Smethurst DominicChief Medical Officer | Sell | 6,097 | $8.30 | $51K |
| Feb 17, 2026 | Hodgson IanChief Operating Officer | Sell | 847 | $7.38 | $6K |
| Feb 13, 2026 | Cohen YuvalChief Executive Officer | Sell | 13,871 | $7.78 | $108K |
| Feb 13, 2026 | Moran Sean F.Chief Financial Officer | Sell | 4,701 | $7.78 | $37K |
| Feb 3, 2026 | Smethurst DominicChief Medical Officer | Sell | 3,285 | $8.09 | $27K |
| Feb 3, 2026 | Hodgson IanChief Operating Officer | Sell | 2,415 | $8.09 | $20K |
| Dec 11, 2025 | Chen BihuaTenPercentOwner | Sell | 30,029 | $11.46 | $344K |
| Oct 27, 2025 | Cohen YuvalChief Executive Officer | Sell | 8,973 | $17.14 | $154K |
| Oct 24, 2025 | Cohen YuvalChief Executive Officer | Sell | 18,660 | $17.01 | $317K |
| Oct 24, 2025 | Moran Sean F.Chief Financial Officer | Sell | 12,981 | $17.02 | $221K |
| Oct 20, 2025 | Altmeyer AnneDirector | Sell | 1,060 | $20.50 | $22K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 14 reputable articles.
MarketWatchCorbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day14h agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors5d agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains12d agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock rises Monday, still underperforms market14d agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock rises Thursday, still underperforms market18d agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains20d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance